What is a stock summary page? Click here for an overview.
Business Description

ThermoGenesis Holdings Inc
NAICS : 339113
SIC : 3821
ISIN : US1571312024
Description
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.84 | |||||
9-Day RSI | 11.67 | |||||
14-Day RSI | 28.44 | |||||
3-1 Month Momentum % | -57.14 | |||||
6-1 Month Momentum % | -99.81 | |||||
12-1 Month Momentum % | -99.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -47.79 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.71 | |||||
EV-to-EBITDA | -0.83 | |||||
EV-to-Revenue | 0.6 | |||||
EV-to-Forward-Revenue | 0.4 | |||||
Earnings Yield (Greenblatt) % | -140.85 | |||||
FCF Yield % | -3580900 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:THMO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ThermoGenesis Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 9.61 | ||
EPS (TTM) ($) | -5.14 | ||
Beta | 0.87 | ||
3-Year Sharpe Ratio | -1.38 | ||
3-Year Sortino Ratio | -1.49 | ||
Volatility % | 127.91 | ||
14-Day RSI | 28.44 | ||
14-Day ATR ($) | 0.000026 | ||
20-Day SMA ($) | 0.0003 | ||
12-1 Month Momentum % | -99.97 | ||
52-Week Range ($) | 0.0001 - 0.9698 | ||
Shares Outstanding (Mil) | 15.85 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ThermoGenesis Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ThermoGenesis Holdings Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
ThermoGenesis Holdings Inc Frequently Asked Questions
What is ThermoGenesis Holdings Inc(THMO)'s stock price today?
The current price of THMO is $0.00. The 52 week high of THMO is $0.97 and 52 week low is $0.00.
When is next earnings date of ThermoGenesis Holdings Inc(THMO)?
The next earnings date of ThermoGenesis Holdings Inc(THMO) is .
Does ThermoGenesis Holdings Inc(THMO) pay dividends? If so, how much?
ThermoGenesis Holdings Inc(THMO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |